Moderna’s updated COVID-19 vaccine wins U.K. approval (update)
Moderna ( NASDAQ: MRNA) has secured regulatory approval in the U.K. and Taiwan for an updated formulation of its COVID-19 mRNA vaccine, Spikevax. U.K. drug regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), authorized Moderna’s ( MRNA) updated COVID-19 vaccine, targeting the JN.1 variant of SARS-CoV-2.